Treatment of <i>Demodex</i> Blepharitis: A Prospective, Randomized, Controlled, Double-Masked Clinical Trial Comparing Topical Lotilaner Ophthalmic Solution, 0.25% Eyedrops to Vehicle-Reference-Cited by-同舟云学术

Treatment of Demodex Blepharitis: A Prospective, Randomized, Controlled, Double-Masked Clinical Trial Comparing Topical Lotilaner Ophthalmic Solution, 0.25% Eyedrops to Vehicle

Published:2022-08-01 Issue: Volume: Page:1-9
ISSN:0927-3948
Container-title:Ocular Immunology and Inflammation
language:en
Short-container-title:Ocular Immunology and Inflammation

Author:

Yeu Elizabeth¹,Holdbrook Mark²,Baba Stephanie N.²,Ceballos Juan Carlos³,Massaro-Corredor Martha³,Corredor-Ortega Claudia³,Ramos-Betancourt Nallely⁴,Quiroz-Mercado Hugo⁵,Gonzalez-Salinas Roberto³^ORCID

Affiliation:

1. Virginia Eye Consultants, Norfolk, Virginia, USA

2. Tarsus Pharmaceuticals, Inc, Irvine, California, USA

3. Anterior Segment Surgery Department, Asociación para Evitar la Ceguera en México I.A.P, Mexico City, Mexico

4. Cornea Department, Asociación para Evitar la Ceguera en México I.A.P, Mexico City, Mexico

5. Research Department, Asociación para Evitar la Ceguera en México I.A.P, Mexico City, Mexico

Funder

Tarsus Pharmaceuticals to Asociacion para Evitar la Ceguera en Mexico I.A.P

Publisher

Informa UK Limited

Subject

Ophthalmology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/09273948.2022.2093755

Reference38 articles.

1. Evaluation of the Efficacy of Tea Tree Oil On the Density ofDemodexMites (Acari: Demodicidae) and Ocular Symptoms In Patients With Demodectic Blepharitis

2. Clinical Treatment of Ocular Demodex folliculorum by Systemic Ivermectin

3. Demodex blepharitis: clinical perspectives

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ocular and Systemic Pharmacokinetics of Lotilaner Ophthalmic Solution, 0.25%, Following a Single Dose or Repeated Doses in Dutch-Belted Rabbits;Journal of Ocular Pharmacology and Therapeutics;2024-08-16

2. Efficacy and Safety of Lotilaner Ophthalmic Solution (0.25%) for the Treatment of Demodex Blepharitis: A GRADE Assessed Systematic Review and Meta-Analysis of Observational & Experimental Studies;American Journal of Ophthalmology;2024-08

3. Lotilaner Ophthalmic Solution, 0.25%, for the Treatment of Demodex Blepharitis;Healthcare;2024-07-26

4. Efficacy and Safety of Lotilaner Ophthalmic Solution 0.25% for the Treatment of Demodex Blepharitis: A Meta-Analysis of Randomized Controlled Trials;Contact Lens and Anterior Eye;2024-06

5. Novel treatments for dry eye syndrome;Current Opinion in Pharmacology;2024-04